Bone metastases from gastrointestinal stromal tumour: Correlation with positron emission tomography-computed tomography

Journal of the Hong Kong College of Radiologists

Volumn 11, Issue 4, 2009, Pages 172-175

  Chu, T Y C ^a,b   Wong, C S ^a  

^a KWONG WAH HOSPITAL   (Hong Kong)

^b NONE   (Hong Kong)

Author keywords

Gastrointestinal stromal tumors; Neoplasm metastasis; Positron emission tomography; Tomography; X ray computed

Indexed keywords

CD34 ANTIGEN; CYTOKERATIN 5; CYTOKERATIN AE1; CYTOKERATIN AE3; DESMIN; FLUORODEOXYGLUCOSE; IMATINIB; STEM CELL FACTOR RECEPTOR;

ADVANCED CANCER; AGED; ARTICLE; BIOPSY; BONE METASTASIS; CASE REPORT; CHEST TIGHTNESS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG UPTAKE; ESOPHAGOGASTRODUODENOSCOPY; GASTROINTESTINAL STROMAL TUMOR; HEMIDIAPHRAGM; HUMAN; IMMUNOHISTOCHEMISTRY; LAPAROTOMY; MALE; MULTIPLE CANCER; PARTIAL GASTRECTOMY; SMALL INTESTINE OBSTRUCTION; SPINDLE CELL; TUMOR RECURRENCE; TUMOR VOLUME;

EID: 66049086158     PISSN: 10295097     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Nguyen V, Taylor A. Gastrointestinal stromal tumors - leiomyoma/ leiomyosarcoma. eMedicine. Available from: http://www.emedicine.com/ radio/topic388.htm Accessed 5 February 2009.
2. Wada Y, Kadokura M, Kamio Y, et al. Esophageal gastrointestinal stromal tumour surrounding the middle esophagus with dysphagia for 8 years; report of a case. Kyobu Geka. 2004;57:1250-3 [Article in Japanese.]
3. Wong CS, Chan T, Chu YC, et al. Oesophageal gastrointestinal stromal tumour presenting with rupture into pleural cavity. H K Med J. 2007;13:478-81.
4. Burkill GJ, Badran M, Al-Muderis O, et al. Malignant gastrointestinal stromal tumor: distribution, imaging features, and pattern of metastatic spread. Radiology. 2003;226:527-32.
5. Ma HT. Imaging in colorectal cancer and GIST. Biomed Imaging Interv J. 2007;3:e12-51.
6. Gayed I, Vu Y, Iyer R, et al. The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumours. J Nucl Med. 2004;45:17-21.
7. Antoch G, Kanja J, Bauer S, et al. Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (SRI571) therapy in patients with gastrointestinal stromal tumours. J Nucl Med. 2004;45:357-65.
8. Kuehl H, Veit P, Rosenbaurn SJ, Bockisch A, Antoch G. Can PET/CT replace separate diagnostic CT for cancer imaging? Optimizing CT protocols for imaging cancers of the chest and abdomen. J Nucl Med. 2007;48(Suppl):S45-57.
9. Holdsworth CH, Badawi RD, Manola JB, et al. CT and PET: early prognostic indicators of response to imatinib mesylate in patients with gastrointestinal stromal tumour. AJR Am J Roentgenol. 2007; 189:W324-30.